Work

Identification of Biomarkers that May Extend the Utility of Anti EGFR Therapies to Subpopulations of Right-Sided and Mutant RAS Metastatic Colorectal Cancer

Year: 2024

Type: preprint

Study design: Observational Study

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.5070292

Authors: Ramya Thota, Nishant Gandhi, Mingli Yang, Michael Schell, Lance Pflieger, Andrey Loboda, Michael Nebozhyn, Ninad Kulkarni, Emily Palombo, Andrew Elliott, Joanne Xiu, George W. Sledge, Moh'd M. Khushman, Emil Lou, SANJAY GOEL, Warren Jack Pledger, Timothy Yeatman

Institutions: Intermountain Healthcare, Caris Life Sciences (United States), University of South Florida, Moffitt Cancer Center, Buck Institute for Research on Aging, Merck & Co., Inc., Rahway, NJ, USA (United States), Washington University in St. Louis, University of Minnesota, Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Tampa General Hospital

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4405901813

Cites:

Cited by:

Related to: 10